These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3273153)

  • 1. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R; Silk KR; Greden JF; Goodson J; Hariharan M; Meador-Woodruff JH; Kronfol Z
    Biol Psychiatry; 1989 Mar; 25(6):788-92. PubMed ID: 2629711
    [No Abstract]   [Full Text] [Related]  

  • 6. The dexamethasone suppression test and residual schizophrenia.
    Harris VJ
    Am J Psychiatry; 1985 May; 142(5):659-60. PubMed ID: 3985211
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between dexamethasone nonsuppression and negative symptoms in schizophrenic patients.
    Tandon R
    Acta Psychiatr Scand; 1989 Nov; 80(5):524-5. PubMed ID: 2574530
    [No Abstract]   [Full Text] [Related]  

  • 8. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
    Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test, schizophrenia and movement disorder.
    Aleem A; Kulkarni A; Yeragani VK
    Acta Psychiatr Scand; 1988 Dec; 78(6):689-94. PubMed ID: 3223326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying major depression with psychosis.
    Clower CG
    Psychiatr Med; 1988; 6(4):66-72. PubMed ID: 3238029
    [No Abstract]   [Full Text] [Related]  

  • 14. Dexamethasone nonsuppression and short rapid eye movement latency in schizophrenia: markers of an affective diathesis?
    Goldman M; Tandon R; Taylor SF; DeQuardo JR; Shipley JE; Patel B; Reddig S; Jibson M
    Biol Psychiatry; 1996 Nov; 40(9):927-9. PubMed ID: 8896782
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA; Flegel P; Cameron OG; Greden JF
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of plasma HVA response to dexamethasone in psychotic depression.
    Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D
    Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dexamethasone Suppression Test in depression, in schizophrenia, and during experimental stress.
    Baumgartner A; Gräf KJ; Kürten I
    Biol Psychiatry; 1985 Jun; 20(6):675-9. PubMed ID: 3995114
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N; Mück-Seler D; Jakovljević M
    Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial dexamethasone suppression tests in male chronic schizophrenic patients.
    Myers ED
    Am J Psychiatry; 1984 Jul; 141(7):904-5. PubMed ID: 6731645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.